Health committee  I think that's probably the biggest barrier: not having an adequate amount of vaccine. The good news is that I do see the numbers picking up for the single dose. It's now heading towards about 40% single dose, so that's better, but still, in terms of full vaccination, the numbers

Health committee  Yes. There were two problems early on that we noticed back in December. Two groups were highly vaccine hesitant. One was black and brown communities, and then conservative groups. There were four news polls, one from PBS NewsHour and others from Monmouth University, Quinnipiac Un

Health committee  Well, unfortunately, in the last administration, the vaccination plan was mostly about providing and ensuring that there would be adequate supply of vaccine. That was clearly important, but it became clear when the new administration took over that the plan and the logistics were

Health committee  Okay.

Health committee  Well, they always have to work with the states, but I think it was in the planning and the coordination of helping to create the sites, helping with the use of the military and the National Guard and making recommendations to the states in terms of opening up some of the big spor

Health committee  They've also provided quite a number of single doses. The numbers overall in the U.S. are 46% single dose and 34% two doses, but in the high-performing states, it's more like 60% and 45%. The reason you could do it was the vaccine supply. There was enough vaccine available from t

Health committee  Unfortunately, I missed the beginning of that question, and my French is just not good enough. Maybe the English translator could just briefly summarize the beginning part?

Health committee  Well, one thing is that we actually did not file any patents for our vaccine. It's free and open to anybody who wants to scale it up and produce it. We do this for practical reasons, because the filing of patents is so expensive, and our biggest concern is access. We provide non-

Health committee  They both work by the same principle. The idea is that the convalescent serum provides virus-neutralizing antibodies, and the monoclonal antibody works that same way. The advantage of the monoclonal antibody, of course, is that there's better quality control, so you know exactly

Health committee  I think the patent waiver could be useful. I have an article that just came out in Foreign Affairs this morning that basically says that the patent waivers are a good development but are insufficient to solve the problem because the problem with vaccines is that they are more com

Health committee  It's good to see everybody, and I appreciate this opportunity.

Health committee  I hope everything is working out well and that I can be understood for the translation.

Health committee  Thank you to the committee for inviting me. Very briefly, I'm an M.D. Ph.D. pediatrician-scientist and I co-lead efforts to develop vaccines for neglected diseases of poverty in addition to coronavirus infection vaccines and a new COVID-19 vaccine. For the last two decades, we'

Health committee  Okay. I'm sorry about that. I'm also a bit of an expert on this anti-vax scenario because my youngest daughter, Rachel, has autism and intellectual disabilities, and I wrote a book previously called Vaccines Did Not Cause Rachel's Autism, which often makes me public enemy numbe